SEC Form 3 · accession 0001179022-17-000073
GALECTIN THERAPEUTICS INC · GALT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen Shulman
Director
Period of report
Dec 14, 2017
Accepted (ET)
Dec 18, 2017 · 4:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001133416
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 12,000 | D |
Table II — derivative securities
No Table II lines on this filing.